Zifi CV 200 Tablet is a combination antibiotic formulation containing Cefixime 200 mg and Clavulanic Acid 125 mg, designed to treat a broad spectrum of bacterial infections. Cefixime, a third-generation cephalosporin, exerts bactericidal activity by inhibiting bacterial cell wall synthesis, effectively targeting various gram-positive and gram-negative pathogens. Clavulanic Acid, a beta-lactamase inhibitor, enhances the efficacy of Cefixime by preventing enzymatic degradation of the antibiotic, thereby overcoming resistance mechanisms in beta-lactamase producing bacteria. This synergistic combination is indicated for the treatment of respiratory tract infections, urinary tract infections, otitis media, skin and soft tissue infections, and other susceptible bacterial infections. Zifi CV 200 Tablet should be administered as prescribed by a healthcare professional, with dosage adjustments based on the severity of infection, patient age, and renal function. Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort, which are generally mild and transient. Hypersensitivity reactions, though rare, require immediate medical attention. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Proper adherence to the prescribed course is essential to prevent antibiotic resistance and ensure therapeutic success.